Travere Therapeutics' Breakout Bid: A Recipe for Caution?
Travere Therapeutics has been making waves in the market, testing its breakout levels and leaving investors wondering if it's time to take a bite of this potential goldmine.
However, a closer examination of the company's recent performance reveals that the picture isn't quite as rosy as it seems.